PECAM1 and cancer: The results showed that CD31 immunostainings were much lower in xenografts generated by USP22−/− cancer cells than their parent cancer cells (Fig. 3d, upper panel), indicating that in vivo angiogenesis was dramatically suppressed upon USP22 knockout.